04:45 AM EDT, 09/15/2026 (MT Newswires) -- Circio Holding (CRNA.OL) said Tuesday it raised 200 million Norwegian kroner in a private placement with international investors. The biotechnology company allocated 16,865,000 shares at 11.80 kroner apiece in the transaction. Proceeds were earmarked for Circio's in vivo CAR-T cell therapy program, particularly its plan to secure DNA vector and T-cell-targeted LNP-delivery systems. Settlement is expected on Thursday. The company is also looking to raise an additional 200 million kroner in a subsequent private placement, subject to a prospectus and its market price.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.